MY113874A - Zwitterionic forms of trovafloxacin - Google Patents

Zwitterionic forms of trovafloxacin

Info

Publication number
MY113874A
MY113874A MYPI96003579A MYPI19963579A MY113874A MY 113874 A MY113874 A MY 113874A MY PI96003579 A MYPI96003579 A MY PI96003579A MY PI19963579 A MYPI19963579 A MY PI19963579A MY 113874 A MY113874 A MY 113874A
Authority
MY
Malaysia
Prior art keywords
trovafloxacin
zwitterionic forms
methods
hygroscopic
formula
Prior art date
Application number
MYPI96003579A
Other languages
English (en)
Inventor
John Meldrum Allen Douglas
Bruning Joseph David
Norris Timothy
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MY113874A publication Critical patent/MY113874A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Physical Water Treatments (AREA)
  • Processing Of Solid Wastes (AREA)
MYPI96003579A 1995-08-29 1996-08-28 Zwitterionic forms of trovafloxacin MY113874A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US297595P 1995-08-29 1995-08-29

Publications (1)

Publication Number Publication Date
MY113874A true MY113874A (en) 2002-06-29

Family

ID=21703460

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI96003579A MY113874A (en) 1995-08-29 1996-08-28 Zwitterionic forms of trovafloxacin

Country Status (30)

Country Link
EP (1) EP0850060A1 (sh)
JP (1) JP3188476B2 (sh)
KR (1) KR100343909B1 (sh)
CN (1) CN1190889A (sh)
AP (1) AP636A (sh)
AR (1) AR003985A1 (sh)
AU (1) AU704115B2 (sh)
BR (1) BR9609998A (sh)
CA (1) CA2229786C (sh)
CO (1) CO4480739A1 (sh)
CZ (1) CZ56698A3 (sh)
DZ (1) DZ2087A1 (sh)
GT (1) GT199600072A (sh)
HR (1) HRP960395B1 (sh)
HU (1) HUP9900170A3 (sh)
IL (1) IL122651A (sh)
MA (1) MA23966A1 (sh)
MY (1) MY113874A (sh)
NO (1) NO309814B1 (sh)
NZ (1) NZ312199A (sh)
OA (1) OA10669A (sh)
PE (1) PE12598A1 (sh)
PL (1) PL325170A1 (sh)
RU (1) RU2144921C1 (sh)
SK (1) SK23898A3 (sh)
TN (1) TNSN96109A1 (sh)
TR (1) TR199800339T1 (sh)
WO (1) WO1997007800A1 (sh)
YU (1) YU48396A (sh)
ZA (1) ZA967282B (sh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000106A (es) 1997-08-01 1999-01-08 Pfizer Prod Inc Composiciones parenterales de alatroflaxacino
US7019142B2 (en) 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
PA8466701A1 (es) * 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino
US6114531A (en) * 1998-07-28 2000-09-05 Pfizer Inc. Process for preparing quinolone and naphthyridone carboxylic acids
HN1999000141A (es) * 1998-09-03 2000-06-19 Pfizer Prod Inc Procedimiento para preparar sales de trovafloxacina de adicion de acidos.
US6239141B1 (en) 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids

Also Published As

Publication number Publication date
TR199800339T1 (xx) 1998-06-22
KR19990044232A (ko) 1999-06-25
AU704115B2 (en) 1999-04-15
MX9801664A (es) 1998-08-30
JPH10511692A (ja) 1998-11-10
IL122651A0 (en) 1998-08-16
HUP9900170A2 (hu) 1999-05-28
EP0850060A1 (en) 1998-07-01
NO980862D0 (no) 1998-02-27
CA2229786A1 (en) 1997-03-06
CN1190889A (zh) 1998-08-19
CZ56698A3 (cs) 1999-02-17
IL122651A (en) 2000-02-17
HRP960395A2 (en) 1998-06-30
ZA967282B (en) 1998-03-02
YU48396A (sh) 1998-12-23
CO4480739A1 (es) 1997-07-09
JP3188476B2 (ja) 2001-07-16
GT199600072A (es) 1998-02-14
BR9609998A (pt) 1999-07-06
CA2229786C (en) 2002-02-19
HRP960395B1 (en) 2001-12-31
AU6367696A (en) 1997-03-19
SK23898A3 (en) 1999-05-07
AR003985A1 (es) 1998-09-30
RU2144921C1 (ru) 2000-01-27
KR100343909B1 (ko) 2003-04-10
WO1997007800A1 (en) 1997-03-06
DZ2087A1 (fr) 2002-07-22
AP9600853A0 (en) 1996-10-31
HUP9900170A3 (en) 1999-11-29
TNSN96109A1 (fr) 2005-03-15
AP636A (en) 1998-04-09
OA10669A (en) 2000-11-06
NO980862L (no) 1998-02-27
MA23966A1 (fr) 1997-04-01
NZ312199A (en) 1999-06-29
PL325170A1 (en) 1998-07-06
NO309814B1 (no) 2001-04-02
PE12598A1 (es) 1998-03-20

Similar Documents

Publication Publication Date Title
MY113733A (en) Salts of an anti-migraine indole derivative
EP0863755A4 (en) ANTITHROMBOTIC DIAMINES
DE69831868D1 (en) Antithrombosemittel
IL133623A0 (en) Antithrombotic agents
BG106340A (en) Substituted oxoazaheterocyclyl compounds
MA23850A1 (fr) Procede de preparation de compositions vaccinantes
MA23918A1 (fr) Procede de preparation de compositions vaccinantes
MY133647A (en) Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates
TW263499B (sh)
MA23814A1 (fr) Procede de preparation de compositions vaccinantes
MX9503529A (es) Derivados de glicinamida, procedimiento para su preparacion y medicamentos que los contienen.
MY132473A (en) Crystalline hydrochloride of (r)-(-)-2-<n-[4-(1,1- dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl)-butyl]-aminomethyl>-chroman
EP0807633A3 (en) Novel 2,3-disubstituted-(5,6)- heteroarylfused-pyrimidine-4-ones
MX9804046A (es) 6-0-metil eritromicina d y proceso para hacerla.
IL113137A0 (en) Pharmaceutical compositions containing carboxylic acid derivatives
MY120683A (en) New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals.
MY113874A (en) Zwitterionic forms of trovafloxacin
EP1019047A4 (en) ANTITHROMBOTIC AGENTS
UA66866C2 (uk) Синтез морфолінових похідних
BG103260A (en) The application of 1-hydroxy-2-pyridons for the treatment of seborrheic dermatitis
EP1027051A4 (en) ANTITHROMBOTIC AGENTS
NZ320522A (en) Piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same and a process for the preparation of the compounds
AP2002002494A0 (en) Hygromycin derivatives.
TW371661B (en) Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides
CA2301590A1 (en) 2-aminopyridines as inhibitors of cyclooxygenase-2